CompletedNot Applicable

Dexcom G6 for Total Pancreatectomy With Islet Autotransplantation (TPIAT) Patients

United States18 participantsStarted 2022-03-01

Plain-language summary

A single-center prospective trial on the effects of standard of care radiation exposure on the Dexcom G6 continuous glucose monitoring (CGM) device.

Who can participate

Age range11 Years – 25 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Planned TPIAT at CCHMC * Staying in-patient at CCHMC post TPIAT * Planned to receive a Dexcom G6 CGM Exclusion Criteria: • Hemo- or peritoneal dialysis

What they're measuring

Dexcom G6 Accuracy Post Radiation Exposure by Clark Error Analysis (Zone A and B %)

Timeframe: 3 months

Post Radiation Dexcom G6 Transmitter Functional Duration by Clark Error Analysis (Zone A and B %)

Timeframe: 3 months

Trial details

NCT IDNCT05607576

SponsorDeborah Elder

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-10-20

Results submitted2024-12-13

View on ClinicalTrials.gov More Diabetes trials